Commit To Purchase Krystal Biotech At $45, Earn 71% Annualized Using Options
August 19, 2021 at 11:52 AM EDT
Investors eyeing a purchase of Krystal Biotech Inc (KRYS) stock, but tentative about paying the going market price of $52.18/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $45 strike, which has a bid at the time of this writing of $10.50..